ES2177622T3 - Forma terapeutica que contiene colestipol con funciones de vehiculo con principios activos acidos y proceso de fabricacion de la misma. - Google Patents

Forma terapeutica que contiene colestipol con funciones de vehiculo con principios activos acidos y proceso de fabricacion de la misma.

Info

Publication number
ES2177622T3
ES2177622T3 ES95904434T ES95904434T ES2177622T3 ES 2177622 T3 ES2177622 T3 ES 2177622T3 ES 95904434 T ES95904434 T ES 95904434T ES 95904434 T ES95904434 T ES 95904434T ES 2177622 T3 ES2177622 T3 ES 2177622T3
Authority
ES
Spain
Prior art keywords
colestipol
active acid
manufacturing process
same
vehicle functions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95904434T
Other languages
English (en)
Inventor
Walter Muller
Karsten Cremer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2177622T3 publication Critical patent/ES2177622T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN MEDICAMENTO ORAL CON UN PORTADOR PARA UN PRINCIPIO ACTIVO ACIDO, EL CUAL DISPONE DE AL MENOS UN GRUPO CARBOXILO LIBRE, QUE ESTA UNIDO IONICAMENTE A UN POLIMERO CON GRUPOS DE AMINAS TERCIARIAS, CARACTERIZADO PORQUE EL POLIMERO ES COLESTIPOL O HIDROCLORURO DE COLESTIPOL.
ES95904434T 1994-01-27 1994-12-08 Forma terapeutica que contiene colestipol con funciones de vehiculo con principios activos acidos y proceso de fabricacion de la misma. Expired - Lifetime ES2177622T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4402379A DE4402379C2 (de) 1994-01-27 1994-01-27 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ES2177622T3 true ES2177622T3 (es) 2002-12-16

Family

ID=6508812

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95904434T Expired - Lifetime ES2177622T3 (es) 1994-01-27 1994-12-08 Forma terapeutica que contiene colestipol con funciones de vehiculo con principios activos acidos y proceso de fabricacion de la misma.

Country Status (22)

Country Link
US (1) US5858344A (es)
EP (1) EP0741574B1 (es)
JP (1) JP3701971B2 (es)
KR (1) KR100439311B1 (es)
AT (1) ATE218371T1 (es)
AU (1) AU697353B2 (es)
CA (1) CA2182417C (es)
CZ (1) CZ291006B6 (es)
DE (2) DE4402379C2 (es)
DK (1) DK0741574T3 (es)
ES (1) ES2177622T3 (es)
FI (1) FI116880B (es)
HU (1) HU223317B1 (es)
IL (1) IL112435A (es)
MY (1) MY113340A (es)
NO (1) NO963143L (es)
NZ (1) NZ277777A (es)
PL (1) PL315619A1 (es)
PT (1) PT741574E (es)
SK (1) SK97296A3 (es)
WO (1) WO1995020394A1 (es)
ZA (1) ZA95638B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403367B1 (en) * 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
DE19615820A1 (de) * 1996-04-06 1997-10-09 Holger Specht Zahnpflegemittel und Verfahren zu seiner Herstellung
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
IN2014DN03102A (es) 2006-11-07 2015-07-10 Procter & Gamble
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
EP4353762A1 (en) 2021-06-07 2024-04-17 University of Tsukuba Polymerized valproic acid and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191762A (en) * 1978-10-19 1982-09-14 Merck & Co Inc Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
DE3366838D1 (en) * 1982-03-01 1986-11-20 Efamol Ltd Pharmaceutical composition
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
CA2040865C (en) * 1990-05-15 2002-07-23 James L. Bergey Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor

Also Published As

Publication number Publication date
DE59410133D1 (de) 2002-07-11
PT741574E (pt) 2002-11-29
EP0741574A1 (de) 1996-11-13
US5858344A (en) 1999-01-12
KR100439311B1 (ko) 2005-08-17
ATE218371T1 (de) 2002-06-15
JP3701971B2 (ja) 2005-10-05
NO963143D0 (no) 1996-07-26
FI962985A0 (fi) 1996-07-26
DE4402379A1 (de) 1995-08-03
PL315619A1 (en) 1996-11-25
DK0741574T3 (da) 2002-09-23
HUT74434A (en) 1996-12-30
MY113340A (en) 2002-01-31
IL112435A (en) 1999-01-26
AU697353B2 (en) 1998-10-01
NZ277777A (en) 1997-01-29
FI962985L (fi) 1996-07-26
CA2182417A1 (en) 1995-08-03
WO1995020394A1 (de) 1995-08-03
CZ221396A3 (en) 1997-01-15
CZ291006B6 (cs) 2002-11-13
NO963143L (no) 1996-09-24
HU9602041D0 (en) 1996-09-30
DE4402379C2 (de) 1997-09-25
FI116880B (fi) 2006-03-31
IL112435A0 (en) 1995-03-30
AU1312795A (en) 1995-08-15
EP0741574B1 (de) 2002-06-05
CA2182417C (en) 2007-04-17
ZA95638B (en) 1995-10-25
HU223317B1 (hu) 2004-05-28
KR970700505A (ko) 1997-02-12
JPH09511488A (ja) 1997-11-18
SK97296A3 (en) 1997-04-09

Similar Documents

Publication Publication Date Title
MX9804969A (es) Dispositivo de distribucion de farmaco.
BR9106842A (pt) Processo para a producao de poli-alfa-olifenas cristalinas com um sistema catalisador de monociclopentadienila-metal de transicao
BR0015611A (pt) Processo de limpeza que utiliza ondas ultra-sÈnicas
DE69333607D1 (de) Vorrichtung zur Herstellung von vorgefüllten, sterilen Abgabevorrichtungen
DE3786407D1 (de) Nukleierungssystem fuer polyamide.
BR9504008A (pt) Processo para produzir uma poliolefina tendo uma distribuição de peso molecular major do que 3 e sistema catalisador
SV1996000026A (es) Benzociclopentano oxazolidinonas que contienen heteroatomos
BR8805553A (pt) Processo para a producao de um homopolimero ou copolimero de etileno;e sistema catalisador misto
SE9504495D0 (sv) Linjär blockpolymer innefattande urea- och uretangrupper, förfarande för framställning av linjära blockpolymerer samt användning av blockpolymererna som implantat
ES2103379T3 (es) Catalizadores de estaño para la hidrolisis de agentes de curado aminicos latentes.
BR0015622A (pt) Processo de limpeza que utiliza ondas ultra-sÈnicas
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
ID25950A (id) Katalis-katalis untuk memproduksi aldehid tidak jenuh dan asam karboksilat tidak jenuh dan proses untuk produksi aldehid tidak jenuh dan asam karboksilat tidak jenuh menggunakan katalis
FR2695714B1 (fr) Installation de traitement cryogénique, notamment de distillation d'air.
ES2177622T3 (es) Forma terapeutica que contiene colestipol con funciones de vehiculo con principios activos acidos y proceso de fabricacion de la misma.
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
ES2174533T3 (es) Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas.
ID26985A (id) Amina-amina polisiklik tiazolidin-2-ilidena, proses pembuatannya, dan penggunaannya a sebagai bahas farmasi
ES2105349T3 (es) Procedimiento para fabricar poliamidas parcialmente aromaticas que contienen unidades de 2-metilpentametilendiamina.
DE59606907D1 (de) Arzneiform zur abgabe von kollagenase an wunden und verfahren zu ihrer herstellung
MY130107A (en) Piperidylmethyl-substituted chroman derivatives
ID21209A (id) Turunan benzopiran tersubstitusi-sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung senyawa tersebut
DE3786199D1 (de) Artikel fuer die verabreichung pharmakologisch aktiver substanzen.
BR9405129A (pt) Sistema catalisador;processo para a polimerzação de etileno;processo para a produção de uma composição de tricloreto de titânio
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용